UBS Group’s Metacrine, Inc. Common Stock MTCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-4,781
| Closed | -$2.15K | – | 9994 |
|
|
2022
Q4 | $2.15K | Sell |
4,781
-37,870
| -89% | -$17K | ﹤0.01% | 8528 |
|
|
2022
Q3 | $21K | Buy |
42,651
+32,078
| +303% | +$15.8K | ﹤0.01% | 6276 |
|
|
2022
Q2 | $5K | Sell |
10,573
-15,490
| -59% | -$7.33K | ﹤0.01% | 7951 |
|
|
2022
Q1 | $16K | Buy |
26,063
+24,469
| +1,535% | +$15K | ﹤0.01% | 6742 |
|
|
2021
Q4 | $1K | Buy |
1,594
+599
| +60% | +$376 | ﹤0.01% | 9000 |
|
|
2021
Q3 | $3K | Sell |
995
-504
| -34% | -$1.52K | ﹤0.01% | 7737 |
|
|
2021
Q2 | $6K | Sell |
1,499
-876
| -37% | -$3.51K | ﹤0.01% | 7381 |
|
|
2021
Q1 | $15K | Buy |
2,375
+895
| +60% | +$5.65K | ﹤0.01% | 6623 |
|
|
2020
Q4 | $12K | Buy |
1,480
+965
| +187% | +$7.82K | ﹤0.01% | 6350 |
|
|
2020
Q3 | $5K | Buy |
+515
| New | +$5K | ﹤0.01% | 6475 |
|